191 related articles for article (PubMed ID: 31375156)
1. Expression of Oxytocin Receptors in Canine Mammary Tumours.
Benavente MA; Bianchi CP; Aba MA
J Comp Pathol; 2019 Jul; 170():26-33. PubMed ID: 31375156
[TBL] [Abstract][Full Text] [Related]
2. Expression of Arginine Vasopressin Type 2 Receptor in Canine Mammary Tumours: Preliminary Results.
Benavente MA; Bianchi CP; Aba MA
J Comp Pathol; 2020 Aug; 179():36-40. PubMed ID: 32958145
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
Mainenti M; Rasotto R; Carnier P; Zappulli V
Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
[TBL] [Abstract][Full Text] [Related]
4. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Hypoxia-Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary Tumours.
Shin JI; Lim HY; Kim HW; Seung BJ; Sur JH
J Comp Pathol; 2015; 153(2-3):101-10. PubMed ID: 26145724
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
[TBL] [Abstract][Full Text] [Related]
9. Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours.
Guimarães MJ; Carvalho MI; Pires I; Prada J; Gil AG; Lopes C; Queiroga FL
J Comp Pathol; 2014 Jan; 150(1):27-34. PubMed ID: 24060154
[TBL] [Abstract][Full Text] [Related]
10. Tumour-associated macrophages: Relation with progression and invasiveness, and assessment of M1/M2 macrophages in canine mammary tumours.
Monteiro LN; Rodrigues MA; Gomes DA; Salgado BS; Cassali GD
Vet J; 2018 Apr; 234():119-125. PubMed ID: 29680383
[TBL] [Abstract][Full Text] [Related]
11. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
13. CD204-Expressing Tumor-Associated Macrophages Are Associated With Malignant, High-Grade, and Hormone Receptor-Negative Canine Mammary Gland Tumors.
Seung BJ; Lim HY; Shin JI; Kim HW; Cho SH; Kim SH; Sur JH
Vet Pathol; 2018 May; 55(3):417-424. PubMed ID: 29343199
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Hyperplasia, Neoplasia and Supporting Stroma.
Levi M; Brunetti B; Sarli G; Benazzi C
J Comp Pathol; 2016 Nov; 155(4):277-285. PubMed ID: 27528038
[TBL] [Abstract][Full Text] [Related]
15. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia.
Saad ES; Milley KM; Al-Khan AA; Nimmo JS; Bacci B; Tayebi M; Day MJ; Richardson SJ; Danks JA
J Comp Pathol; 2017 May; 156(4):352-365. PubMed ID: 28449818
[TBL] [Abstract][Full Text] [Related]
16. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours.
Geraldes M; Gärtner F; Schmitt F
Vet Rec; 2000 Apr; 146(14):403-6. PubMed ID: 10791469
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
